Weight loss treatment with semaglutide.How does it work?

by Total Compounding Pharmaceuticals Total Compounding Pharmaceuticals

Semaglutide is a medicine that has been found to help people lose weight. It belongs to the GLP-1 receptor agonist pharmacological class. While semaglutide was created to treat type 2 diabetes, its potential application in weight management has also been examined.

When taken for weight loss, semaglutide is given at a larger dose than when used for diabetes therapy. It is marketed as Wegovy (2.4 mg once weekly) and is indicated for chronic weight management in people with a BMI of 30 kg/m2 or higher, or a BMI of 27 kg/m2 or higher with at least one weight-related comorbidities.

Semaglutide has been shown in clinical trials to cause considerable weight loss. Individuals who took semaglutide in conjunction with lifestyle changes lost more weight than those who received a placebo in tests. The precise process by which semaglutide assists weight loss is unknown, however, it is thought to affect on parts of the brain that regulate appetite and food intake.

It is crucial to know that, like any medication, semaglutide may cause nausea, vomiting, diarrhea, or constipation. These adverse effects are usually modest and fade away with time. To ensure safety and success, like with any weight reduction medication, it is critical to adhere to the recommended dosage and speak with a healthcare practitioner. Semaglutide for weight loss treatment is done under professional guidance to get effective results.